HPS Pharmacies wish to advise that Eli Lilly is experiencing a supply interruption for Trulicity® as follows:
Dulaglutide (rch) 1.5 mg/0.5 mL
This supply interruption is due to an unexpected increase in demand. Normal supplies are expected to return by end-August 2022. An internationally registered brand of dulaglutide (rch) 1.5 mg/0.5 mL pens has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Eli Lilly on 1800 454 559 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates